<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2307">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04360486</url>
  </required_header>
  <id_info>
    <org_study_id>S-20-02</org_study_id>
    <secondary_id>IND 19930</secondary_id>
    <nct_id>NCT04360486</nct_id>
  </id_info>
  <brief_title>Treatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP)</brief_title>
  <official_title>Expanded Access Protocol For The Treatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>U.S. Army Medical Research and Development Command</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>U.S. Army Medical Research and Development Command</source>
  <brief_summary>
    <textblock>
      This treatment protocol is designed to provide a treatment option for patients diagnosed with&#xD;
      severe or life-threatening COVID-19 or judged by the subinvestigator (treating physician) to&#xD;
      be at high risk of progressing to severe or life threatening disease&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an expanded access open-label, single-arm, multi-site protocol to provide&#xD;
      convalescent plasma as a treatment for patients diagnosed with severe, or life-threatening&#xD;
      COVID-19. Efficacy of this treatment will not be evaluated. A single site will initially be&#xD;
      established. When additional patients needing therapy are identified at other health care&#xD;
      facilities, Force Health Protection (FHP) will send a protocol package, and a site will be&#xD;
      established and approved by the Headquarters USAMRDC Institutional Review Board (HQ IRB)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Available</overall_status>
  <study_type>Expanded Access</study_type>
  <expanded_access_info>
    <expanded_access_type_treatment>Yes</expanded_access_type_treatment>
  </expanded_access_info>
  <condition>Severe Acute Respiratory Syndrome Coronavirus 2</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Anti-Sars-CoV-2 Convalescent Plasma</intervention_name>
    <description>Fresh frozen plasma, Plasma Frozen for 24 hours (PF-24), or Liquid plasma</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        A patient must meet the following criteria to be included in this protocol:&#xD;
&#xD;
          -  DoD personnel covered by the Force Health Protection (FHP) program under the&#xD;
             Department of Defense Instruction (DoDI) 6200.02 (active duty service members OCONUS&#xD;
             and CONUS) and non-DoD personnel who may be treated for COVID-19 at Military Treatment&#xD;
             Facilities (MTFs) under the authority of DoDI 6200.03, including Military Health&#xD;
             System (MHS) beneficiaries, patients admitted to MTFs, and patients cared for under&#xD;
             defense support for civilian authorities (e.g. hospital ships, field hospitals&#xD;
             deployed for the COVID-19 response).&#xD;
&#xD;
          -  Laboratory confirmed COVID-19 diagnosis&#xD;
&#xD;
          -  Severe or life threatening COVID-19 disease, or judged by the sub-investigator&#xD;
             (treating physician) to be at high risk for progression to severe or life-threatening&#xD;
             disease&#xD;
&#xD;
          -  Informed consent provided by the patient or legally authorized representative (LAR),&#xD;
             except in situations described in 21 CFR 50.23&#xD;
&#xD;
          -  Understands and agrees to comply with planned protocol procedures&#xD;
&#xD;
          -  Patient agrees to storage of specimens for future testing.&#xD;
&#xD;
        Generally, treatment should be reserved for patients with severe or life-threatening&#xD;
        COVID-19 defined as:&#xD;
&#xD;
        Severe COVID-19 in adults is defined by one or more of the following:&#xD;
&#xD;
          -  Dyspnea&#xD;
&#xD;
          -  Respiratory frequency &gt;/= 30/min&#xD;
&#xD;
          -  Blood oxygen saturation &lt;/= 93%&#xD;
&#xD;
          -  Partial pressure of arterial oxygen to fraction of inspired oxygen ratio &lt; 300&#xD;
&#xD;
          -  Lung infiltrates &gt; 50% within 24 to 48 hours; i.e. infiltrates increase by &gt; 50% in&#xD;
             less than 2 days&#xD;
&#xD;
        Life-threatening COVID-19 is defined as one or more of the following:&#xD;
&#xD;
          -  Respiratory failure&#xD;
&#xD;
          -  Septic shock&#xD;
&#xD;
          -  Multiple organ dysfunction or failure&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Any patient not meeting the inclusion criteria will not be eligible to receive this&#xD;
        treatment. Patients will not be excluded because of receipt of another investigational&#xD;
        COVID-19 treatment, for example: Remdesivir, unless the treating physician sub-investigator&#xD;
        (treating physician) feels that the patient would be put at risk by receiving multiple&#xD;
        investigational therapies.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Andrew P Cap, MS, MD, PhD, FACP</last_name>
    <phone>210-539-4858</phone>
    <email>andrew.p.cap.mil@mail.mil</email>
  </overall_contact>
  <location>
    <facility>
      <name>Naval Hospital Camp Pendleton</name>
      <address>
        <city>Oceanside</city>
        <state>California</state>
        <zip>92055</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Meghan E Ginn</last_name>
      <phone>630-334-3541</phone>
      <email>meghan.e.ginn.mil@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Chase A Hughes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Navy Medical Center San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92134</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Christina M Jamros, DO</last_name>
      <phone>619-532-7475</phone>
      <email>christina.m.jamros.mil@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Christina M Jamros, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>USS Abraham Lincoln</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Mauer Biscotti, MD</last_name>
      <phone>619-595-1609</phone>
      <email>mauer.biscotti.mil@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Mauer Biscotti, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>USS Carl Vinson</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Andrew Nop</last_name>
      <phone>360-627-2537</phone>
      <email>andrew.nop@cvn70.navy.mil</email>
    </contact>
    <investigator>
      <last_name>Andrew Peters, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>USS Essex</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Nelly Rice, MD</last_name>
      <phone>619-556-4768</phone>
      <email>nelly.rice@navy.mil</email>
    </contact>
    <investigator>
      <last_name>Nelly Rice, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>USS Makin Island</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Adolfo Granados, DO</last_name>
      <phone>619-545-8486</phone>
      <email>adolfo.granados@lhd8.navy.mil</email>
    </contact>
    <investigator>
      <last_name>Adolfo Granados, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>USS Nimitz</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Gilbert Seda, MD</last_name>
      <phone>619-545-0485</phone>
      <email>gilbert.seda@cvn68.navy.mil</email>
    </contact>
    <investigator>
      <last_name>Gilbert Seda, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>USS Theodore Roosevelt</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Kathleen A Cannon, MD</last_name>
      <phone>914-523-0435</phone>
      <email>kathleen.a.cannon6.mil@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Kathleen A Cannon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Evans Army Community Hospital</name>
      <address>
        <city>Fort Carson</city>
        <state>Colorado</state>
        <zip>80913</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Chandra Punch, MD</last_name>
      <phone>719-526-3682</phone>
      <email>chandra.punch.mil@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Chandra Punch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Eglin Air Force Base</name>
      <address>
        <city>Eglin Air Force Base</city>
        <state>Florida</state>
        <zip>32542</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>David A Boyd, MD</last_name>
      <phone>850-883-8257</phone>
      <email>david.a.boyd22.ctr@mail.mil</email>
    </contact>
    <investigator>
      <last_name>David A Boyd, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Naval Hospital Jacksonville</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Almer B Mendoza</last_name>
      <phone>904-542-7087</phone>
      <email>almer.b.mendoza.ctr@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Alexandra V Perry, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Martin Army Community Hospital</name>
      <address>
        <city>Fort Benning</city>
        <state>Georgia</state>
        <zip>31905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Stacy A Carey, MA</last_name>
      <phone>706-617-4283</phone>
      <email>stacy.a.carey2.civ@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Joshua S Will, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Eisenhower Army Medical Center</name>
      <address>
        <city>Fort Gordon</city>
        <state>Georgia</state>
        <zip>30905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Susan D Rogers</last_name>
      <phone>706-787-2100</phone>
      <email>susan.d.rogers.civ@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Heather S Pomerantz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tripler Army Medical Center</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96859</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Catherine Uyehara, PhD</last_name>
      <phone>808-433-7163</phone>
      <email>catherine.yamauchi2.civ@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Cristian S Madar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Keesler Medical Center</name>
      <address>
        <city>Biloxi</city>
        <state>Mississippi</state>
        <zip>39534</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Earnest M Mann</last_name>
      <phone>228-376-4917</phone>
      <email>earnest.m.mann.civ@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Frederic A Rawlins, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nellis Air Force Base</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89191</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Jill M Clark</last_name>
      <phone>702-653-3298</phone>
      <email>jill.m.clark15.ctr@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Stephanie M Streit, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Naval Medical Center Camp Lejeune</name>
      <address>
        <city>Camp Lejeune</city>
        <state>North Carolina</state>
        <zip>28547</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Chemely M Walker</last_name>
      <phone>910-450-3460</phone>
      <email>chemely.m.walker.civ@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Michael J Monson, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wright Patterson Medical Center</name>
      <address>
        <city>Wright-Patterson Air Force Base</city>
        <state>Ohio</state>
        <zip>45433</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Gregory M Buchek, MD</last_name>
      <phone>203-645-5737</phone>
      <email>gregory.m.buchek.mil@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Gregory M Buchek, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>William Beaumont Army Medical Center</name>
      <address>
        <city>El Paso</city>
        <state>Texas</state>
        <zip>79920</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Larissa A Schmersal, PhD</last_name>
      <phone>915-742-9502</phone>
      <email>larissa.a.schmersal.civ@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Rupal M Mody, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brooke Army Medical Center</name>
      <address>
        <city>Fort Sam Houston</city>
        <state>Texas</state>
        <zip>78234</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Amanda R Wagner</last_name>
      <phone>210-539-9006</phone>
      <email>amanda.r.wagner18.civ@mail.mil</email>
    </contact>
    <investigator>
      <last_name>John L Kiley, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fort Belvoir Community Hospital</name>
      <address>
        <city>Fort Belvoir</city>
        <state>Virginia</state>
        <zip>22060</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Derek T Larson, DO</last_name>
      <phone>571-231-1588</phone>
      <email>derek.t.larson2.mil@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Derek T Larson, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Naval Surface Force Atlantic</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23511</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Jonathan Levenson, RN</last_name>
      <phone>757-444-1966</phone>
      <email>jonathan.levenson@navy.mil</email>
    </contact>
    <investigator>
      <last_name>Rees L Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>USS Dwight D. Eisenhower</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23511</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Jason R Bernhard, MD</last_name>
      <phone>757-443-7452</phone>
      <email>jason.bernhard@cvn69.navy.mil</email>
    </contact>
    <investigator>
      <last_name>Jason R Bernhard, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>USS Gerald R. Ford</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23511</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Gregory Saracco, MD</last_name>
      <phone>757-443-8929</phone>
      <email>gregory.saracco@cvn78.navy.mil</email>
    </contact>
    <investigator>
      <last_name>Gregory Saracco, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Naval Medical Center Portsmouth</name>
      <address>
        <city>Portsmouth</city>
        <state>Virginia</state>
        <zip>23708</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Veotria A Byrd</last_name>
      <phone>757-953-5834</phone>
      <email>veotria.a.byrd.ctr@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Ian A Grasso, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Madigan Army Medical Center</name>
      <address>
        <city>Lakewood</city>
        <state>Washington</state>
        <zip>98431</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Silvija Salai, PhD</last_name>
      <phone>253-968-0147</phone>
      <email>silvija.salai.civ@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Anjali N Kunz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Craig Joint Theatre Hospital Bagram AFGH</name>
      <address>
        <city>Bagram</city>
        <country>Afghanistan</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Vivian F Barlos, PhD</last_name>
      <phone>+49 (0) 6371 94646186</phone>
      <email>vivian.f.barlos.civ@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Daniel Weinstein, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Djibouti Expeditionary Medical Facility</name>
      <address>
        <city>Djibouti</city>
        <country>Djibouti</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Vivian F Barlos, PhD</last_name>
      <phone>+49 (0) 6371 94646186</phone>
      <email>vivian.f.barlos.civ@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Daniel Weinstein, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Landstuhl Regional Medical Center</name>
      <address>
        <city>Landstuhl</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Vivian F Barlos, PhD</last_name>
      <phone>+49 (0) 6371 94646186</phone>
      <email>vivian.f.barlos.civ@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Daniel Weinstein, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Naval Hospital Guam</name>
      <address>
        <city>Agaña</city>
        <country>Guam</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Gavin W Ford, MD</last_name>
      <phone>671-483-9238</phone>
      <email>gavin.w.ford.mil@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Gavin W Ford, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baghdad Diplomat Support Center Iraq</name>
      <address>
        <city>Baghdad</city>
        <country>Iraq</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Vivian F Barlos, PhD</last_name>
      <phone>+49 (0) 6371 94646186</phone>
      <email>vivian.f.barlos.civ@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Daniel Weinstein, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Misawa Air Force Base</name>
      <address>
        <city>Aomori</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Wesley A Roberts, MD</last_name>
      <phone>315-226-6372</phone>
      <email>wesley.a.roberts19.mil@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Wesley A Roberts, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yokota Air Base</name>
      <address>
        <city>Fussa</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Anit Sharma, MD</last_name>
      <phone>DSN 315-225-9255</phone>
      <email>anit.sharma.mil@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Anit Sharma, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>US Naval Hospital Okinawa</name>
      <address>
        <city>Okinawa</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Steven P Praske, DO</last_name>
      <phone>+81-80-6480-6475</phone>
      <email>steven.p.praske.mil@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Steven P Praske, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Naval Hospital Yokosuka</name>
      <address>
        <city>Yokosuka</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Marshall M Hoffman, MD</last_name>
      <phone>DSN 315-243-7442</phone>
      <email>marshall.m.hoffman.mil@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Marshall M Hoffman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>USS America</name>
      <address>
        <city>Yokosuka</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Drake H Tilley, MD</last_name>
      <phone>095601308</phone>
      <email>drake.h.tilley.mil@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Drake H Tilley, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>USS Ronald Reagan</name>
      <address>
        <city>Yokosuka</city>
        <country>Japan</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Justin Lafreniere, MD</last_name>
      <email>justin.lafreniere@cvn76.navy.mil</email>
    </contact>
    <investigator>
      <last_name>Justin Lafreniere, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>US Military Hospital Kuwait</name>
      <address>
        <city>Kuwait</city>
        <country>Kuwait</country>
      </address>
    </facility>
    <status>Available</status>
    <contact>
      <last_name>Vivian F Barlos, PhD</last_name>
      <phone>+49 (0) 6371 94646186</phone>
      <email>vivian.f.barlos.civ@mail.mil</email>
    </contact>
    <investigator>
      <last_name>Daniel Weinstein, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Afghanistan</country>
    <country>Djibouti</country>
    <country>Germany</country>
    <country>Guam</country>
    <country>Iraq</country>
    <country>Japan</country>
    <country>Kuwait</country>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>April 20, 2020</study_first_submitted>
  <study_first_submitted_qc>April 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2020</study_first_posted>
  <last_update_submitted>January 14, 2021</last_update_submitted>
  <last_update_submitted_qc>January 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronavirus Infections</mesh_term>
    <mesh_term>Severe Acute Respiratory Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

